Guardant Health, Inc. GH

About Guardant Health, Inc. (GH): stock profile, AI score and financials

Guardant Health, Inc. (GH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores GH at 39.1/100 on a composite quality score built from its SEC filings, placing it at rank #2,152 of 2,925 stocks — the bottom half of the AI-ranked universe. GH scores in the top quartile across revenue growth (90.4). Areas of concern include balance sheet strength (8.2) and profitability (13.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 10.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Guardant Health, Inc. reports quarterly revenue of $335.0M, net income of $-120.1M, an operating margin of -38.6%. Top institutional holders of GH by reported 13-F value include BlackRock, PRICE T ROWE ASSOCIATES, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. GH trades on the Nasdaq exchange and files with the SEC under CIK 1576280. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Guardant Health, Inc. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1576280 →